The absence of CD56 on malignant plasma cells in the cerebrospinal fluid is the hallmark of multiple myeloma involving central nervous system

British Journal of Haematology

Volumn 129, Issue 4, 2005, Pages 539-541

  Chang, Hong ^a   Bartlett, Eric S ^a   Patterson, Bruce ^a   Chen, Chris I ^a   Yi, Qi Long ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

CD56; CNS involvement; Multiple myeloma

Indexed keywords

CD56 ANTIGEN;

ADULT; ANTIGEN DETECTION; ARTICLE; BONE MARROW CELL; CANCER CELL; CENTRAL NERVOUS SYSTEM TUMOR; CEREBROSPINAL FLUID CYTOLOGY; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MULTIPLE MYELOMA; MYELOMA CELL; PATHOGENESIS; PLASMA CELL; PRIORITY JOURNAL;

ANTIGENS, CD56; BONE MARROW; CENTRAL NERVOUS SYSTEM DISEASES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PLASMA CELLS;

EID: 20044388164     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05493.x     Document Type: Article

References (12)

1. Chang, H., Sloan, S., Li, D. & Stewart, A.K. (2004) Multiple myeloma involving central nervous system: high frequency of p53 deletions. British Journal of Haematology, 127, 280-284.
2. Dahl, I.M., Rasmussen, T., Kauric, G. & Husebekk, A. (2002) Differential expression of CD56 and CD44 in the evolution of extramedullary myeloma. British Journal of Haematology, 116, 273-277.
3. Ely, S.A. & Knowles, D.A. (2002) Expression of CD56/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma cells from monoclonal gammopathy of undetermined significance and lymphoma with plasmacytoid differentiation. American Journal of Pathology, 160, 1293-1299.
4. Fassas, A.B-T., Muwalla, F., Berryman, T., Benramdane, R., Joseph, L., Anaissie, E., Sethi, R., Desikan, R., Siegel, D., Badros, A., Toor, A., Zangari, M., Morris, O., Angtuaco, E., Mathew, S., Wilson, C., Hough, A., Harik, S., Barlogie, B. & Tricot, G. (2002) Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations. British Journal of Haematology, 117, 103-108.
5. Kaiser, U., Auerbach, B. & Oldenburg, M. (1996) The neural cell adhesion molecule NCAM in multiple myeloma. Leukemia & lymphoma, 20, 389-395.
6. Martin, P., Santon, A. & Bellas, C. (2004) Neural cell adhesion molecule expression in plasma cell bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis. Histopathology, 44, 375-380.
7. Pellat-Deceunynck, C., Barillle, S., Puthier, D., Robillard, N., Pineau, D., Rapp, M.J., Harousseau, J.L., Amiot, M. & Bataille, R. (1998) The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and a special subset of multiple myeloma. Leukemia, 12, 1977-1982.
8. Rawstron, A., Barrans, S., Blythe, D., Davis, F., English, A., Pratt, G., Child, A., Morgan, G. & Jack, A. (1999) Distribution of myeloma plasma cells in peripheral blood and bone marrow correlates with CD56 expression. British Journal of Haematology, 104, 138-143.
9. Sahara, N., Takeshita, A., Shigeno, K., Fujisawa, S., Takeshita, K., Naito, K., Ihara, M., Ono, T., Tamashima, A. & Nara, K. (2002) Clinicopathological and prognostic characteristics of CD56-negative multiple myeloma. British Journal of Haematology, 117, 882-885.
10. Schluterman, K.O., Fassas, A.B., Van Hemert, R.L. & Harik, S.I. (2004) Multiple myeloma invasion of the central nervous system. Archive of Neurology, 61, 1423-1429.
11. Schwartz, T.H., Rhiew, R., Isaacson, S.R., Orazi, A. & Bruce, J.N. (2001) Association between intracranial plasmacytoma and multiple myeloma: clinicopathological outcome study. Neurosurgery, 49, 1039-1045.
12. Van Camp, B., Durie, B.C., Spier, C., De Waele, M., Van Riet, I., Vela, E., Frutiger, Y., Richter, L. & Grogan, T.M. (1990) Plasma cell in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19). Blood, 76, 377-382.